Daniel Boster

Daniel Boster has over 20 years of work experience in the field of scientific research and development. Daniel is currently working as an Associate Director at Mozart Therapeutics, Inc since 2022. Prior to their current position, they held the role of Associate Director at Nexelis from 2020 to 2022. At Nexelis, they also served as a Principal Scientist from 2020 to 2021. Before joining Nexelis, Daniel worked as a Senior Scientist at Alder Biopharmaceuticals Inc. from 2016 to 2020. Daniel also worked as a Scientist Supervisor at SNBL USA from 2015 to 2016. Earlier in their career, they held the position of Senior Associate Scientist at Amgen from 2013 to 2015. Daniel's career started at Bristol-Myers Squibb / ZymoGenetics, where they worked as a Senior Scientist from 2002 to 2012. Daniel began their professional journey as a Research Technician II at Seattle Children's Hospital from 1999 to 2002. Daniel's first role in the industry was as a Research Technician I at the University of Washington - Bioengineering Department from 1997 to 1999. Throughout their career, Daniel has gained expertise in assay development, qualification, validation, immunology, bioanalytical sciences, and molecular biology. Daniel has a proven track record of successfully supporting FDA filings and IND submissions.

Daniel Boster attended the University of Washington from 1995 to 1999, where they earned a Bachelor of Science degree in Molecular and Cellular Biology.